
News|Articles|March 1, 2002
Arixtra (Fondaparinux sodium injection), Organon/Sanofi-Synthelabo
New biologic: Factor Xa inhibitor for reducing risk of blood clotsafter orthopedic surgeries
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Health Begins at Home: Why Housing Has Become a Strategic Priority for Managed Care
2
A conversation with Dolores Malaspina, M.D., about the generational impact of Holocaust trauma on schizophrenia risk
3
Intervention boosts connected insulin pen adoption among minorities with Type 1 diabetes
4
Could uveitis in patients with melanoma being treated with immune checkpoint inhibitors be a good thing?
5


























